Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer

SAN DIEGO, Sept. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a developer of innovative pharmaceuticals, announced today the appointment of Sapna Srivastava, Ph.D., to the position of Chief Financial and Strategy Officer. Dr. ... Biopharmaceuticals, Personnel Abide Therapeutics, serine hydrolase
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news